Molecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.

Transcription

1 Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine

2 Molecular testing has become the primary tool for precision medicine. NeoGenomics is a full-service cancer diagnostic laboratory committed to helping the cancer community incorporate informative, effective, and innovative tests into the care of their patients. With over 155 molecular assays in-house, we provide one of the largest oncology-focused molecular test menus available along with top-quality consultation and laboratory services in cytogenetics, FISH, flow cytometry, and IHC. NeoGenomics has developed a unique expertise in analysis and reporting of cancer biomarkers. By having one of the fastest development cycles in the industry, we are also responsive to opportunities to improve service and patient care. We rapidly bring our clients state-of-the-art tests for newly reported, significant genetic indicators for disease diagnosis and classification, assessing prognosis, and selecting therapy. Our oncology and pathology clients always have the flexibility to customize their orders to their patient s specific needs. Highlights of Our Molecular Program Include: One of the most comprehensive oncology-focused menus of single-gene and multi-parameter tumor profiles available Full range of molecular diagnostic technologies including next-gen sequencing, quantitative PCR, gold-standard Sanger sequencing, fragment analysis, and SNP microarray Extensive cell-free DNA/RNA liquid biopsy testing capabilities useful for diagnostic screening, monitoring and detecting minimal residual disease All complementary testing methods including morphology, cytogenetics, FISH, flow cytometry, and IHC are available in-house, which maximizes yield from small specimens and minimizes TAT Growing hereditary cancer testing menu using leading-edge platforms Pharma Services supporting academic institutions, pharmaceutical companies, and the biotechnology industry Testing enhancements to improve detection of low-level abnormalities in select assays through plasma analysis and high-sensitivity sequencing Molecular Testing Capabilities Somatic Germline Early Detection/ Prediction 2 NeoGenomics Laboratories

3 Solid Tumor Tests All Tumors Microsatellite Instability Analysis (MSI) NeoARRAY SNP/Cytogenetic Profile NeoLAB Solid Tumor Monitor NeoTYPE Discovery Profile for Solid Tumors NeoTYPE Precision Profile for Solid Tumors Tumor Mutation Burden Universal Expression/Fusion Profile Brain ATRX viii Analysis IDH1/IDH2 MGMT Promoter Methylation NeoTYPE Brain Tumor Profile TERT Promoter Breast NeoTYPE Breast Tumor Profile Cervical RAF NeoTYPE Cervical Tumor Profile NOTCH1 Colorectal Exon 4 Microsatellite Instability Analysis (MSI) MLH1 Promoter Methylation NeoTYPE Colorectal Tumor Profile NeoTYPE GI Predictive Profile NOTCH1 Exon 4 RAS/RAF Panel Esophageal NeoTYPE Esophageal Tumor Profile NeoTYPE GI Predictive Profile Gastric NeoTYPE Gastric Tumor Profile NeoTYPE GI Predictive Profile GIST NeoTYPE GIST Profile Lung ALK MET MET Exon 14 Deletion Analysis NeoLAB T790M - NeoTYPE Lung Tumor Profile NGS ALK, NTRK, RET, ROS1 Fusion Profile NGS ALK, RET, ROS1 Fusion Profile Oncomine Dx Target Test Melanoma NeoARRAY SNP/Cytogenetic Profile NeoTYPE Melanoma Profile TERT Promoter Ovarian NeoTYPE Ovarian Tumor Profile TP53 Soft Tissue NeoTYPE Liposarcoma Fusion Profile NeoTYPE Soft Tissue Tumor Profile NGS Comprehensive Sarcoma Fusion Profile NGS Ewing Sarcoma Fusion Profile NGS Non-Ewing Sarcoma Fusion Profile NGS Pediatric Sarcoma Fusion Profile NGS Rhabdomyosarcoma Fusion Profile Prostate Androgen Receptor Mutation Analysis HSD3B1 Genotyping NeoLAB Prostate - Thyroid HRAS NeoTYPE Thyroid Profile NGS ALK, NTRK, RET, ROS1 Fusion Profile NGS ALK, RET, ROS1 Fusion Profile NGS Thyroid Fusion Profile TERT Promoter Other Tumors HPV DNA Tissue Testing NeoTYPE Head & Neck Tumor Profile NeoTYPE Liver/Biliary Tumor Profile NeoTYPE Other Solid Tumor Profile NeoTYPE Pancreas Tumor Profile NeoGenomics Laboratories 3

4 Hematologic Diseases Leukemias AML ASXL1 CEBPA DNMT3A ETV6-RUNX1 t(12;21) FLT3 IDH1 IDH2 Inv(16) CBFB-MYH11 NeoLAB AML Profile - NeoLAB FLT3 Mutation Analysis - NeoLAB IDH2 Mutation Analysis - NeoLAB Inv(16), CBFB-MYH11 Translocation - NeoLAB (c-) Mutation Analysis - Liquid Biopsy NeoLAB Mutation Analysis - NeoLAB NPM1 Mutation Analysis - NeoLAB Mutation Analysis - NeoLAB PML-RARA Translocation, t(16;17) - Liquid Biopsy NeoTYPE AML Favorable Risk Profile NeoTYPE AML Prognostic Profile NPM1 NPM1 MRD Analysis PML-RARA t(15;17) RUNX1 RUNX1-RUNX1T1 t(8;21) TP53 APL PML-RARA t(15;17) ALL ABL1 Kinase Domain Mutation B-Cell Gene Rearrangement BCR-ABL1 t(9;22) ETV6-RUNX1 t(12;21) IgH Clonality/MRD by NGS T-Cell Beta Gene Rearrangement T-Cell Gamma Gene Rearrangement TPMT Genotyping CLL BTK Inhibitor Acquired Resistance Panel BTK IgVH NeoLAB BTK Inhibitor Acquired Resistance Panel - NeoTYPE CLL Prognostic Profile NOTCH1 PLC-Gamma-2 SF3B1 JMML NeoLAB Mutation Analysis - NeoTYPE JMML Profile PTPN11 Other Leukemias Hairy Cell: LGLL: STAT3, T-Cell Lymphomas B-Cell Gene Rearrangement BCL1 t(11;14) BCL2 t(14;18) BTK Inhibitor Acquired Resistance Panel BTK Inhibitor Primary Susceptibility Panel EZH2 IgH Clonality/MRD by NGS MYD88 NeoTYPE AITL/Peripheral T-Cell Lymphoma Profile NeoTYPE Lymphoma Profile RHOA Mutation Analysis T-Cell Beta Gene Rearrangement T-Cell Gamma Gene Rearrangement TET2 Myelodysplastic Syndromes ASXL1 ETV6 EZH2 NeoARRAY SNP/Cytogenetic Profile NeoLAB Mutation Analysis - NeoLAB Mutation Analysis - NeoLAB MDS/CMML Profile - NeoTYPE MDS/CMML Profile PPM1D RUNX1 SF3B1 TET2 TP53 Myeloproliferative Neoplasms BCR-ABL1 t(9;22) BCR-ABL p230 CALR JAK2 Exon JAK2 V617F MPL MPN Extended Reflex Panel MPN Standard Reflex Panel NeoLAB Mutation Analysis - NeoTYPE MPN Profile CML ABL1 BCR-ABL1 t(9;22) CSF3R for acml Plasma Cell Myeloma B-Cell Gene Rearrangement Transplant Chimerism/DNA Fingerprinting 4 NeoGenomics Laboratories

5 Hereditary Cancer Tests BRCA1 Mutation & Del/Dup Analysis BRCA1/2 Mutation & Del/Dup Analysis BRCA2 Mutation & Del/Dup Analysis T790M Germline Mutation Analysis Hereditary Cancer Comprehensive Panel Hereditary Cancer Susceptibility for Pediatrics Hereditary DNA Repair Panel for Prostate Cancer HOXB13 Genotyping Inherited Bone Marrow Failure Panel Lynch Syndrome NeoLAB Tests NeoLAB AML Profile - NeoLAB BTK Inhibitor Acquired Resistance Panel - NeoLAB T790M - NeoLAB FLT3 Mutation Analysis - NeoLAB IDH1 Mutation Analysis - NeoLAB IDH2 Mutation Analysis - NeoLAB inv(16), CBFB-MYH11 Translocation - NeoLAB (c-) Mutation Analysis - NeoLAB Mutation Analysis - NeoLAB MDS/CMML Profile - NeoLAB Myeloid Disorders Profile - NeoLAB NPM1 Mutation Analysis - NeoLAB Mutation Analysis - NeoLAB PML-RARA Translocation, t(15;17) - NeoLAB Prostate - NeoLAB RUNX1-RUNX1T1 (AML-ETO) - NeoLAB Solid Tumor Monitor - NeoGenomics Laboratories 5

6 Test Menu Single Gene Tests ABL1 Kinase Domain ALK Androgen Receptor ASXL1 ATRX B-Cell Gene Rearrangement BCL1 Translocation, t(11;14) BCL2 Translocation, t(14;18) BCR-ABL1 Non-Standard p230 BCR-ABL1 Standard p210, p190 BRCA1 Mutation & Del/Dup Analysis BRCA2 Mutation & Del/Dup Analysis BTK CALR CARD11 CBL CD79B CEBPA Chimerism/DNA Fingerprinting CSF3R CXCR4 DNMT3A T790M Germline Mutation Analysis viii Analysis EPCAM Mutation & Del/Dup Analysis ETV6 ETV6-RUNX1 Translocation, t(12;21) EZH2 FLT3 GNAS HOXB13 Genotyping HPV DNA Tissue Testing HRAS HSD3B1 Genotyping IDH1 & IDH2 IgH Clonality/MRD by NGS IgVH Inv(16), CBFB-MYH11 Translocation JAK2 Exon JAK2 V617F Exon 4 MET (c-met) MET Exon 14 Deletion Analysis MGMT Promoter Methylation Microsatellite Instability MLH1 Mutation & Del/Dup Analysis MLH1 Promoter Methylation MPL MYD88 MSH2 Mutation & Del/Dup Analysis MSH6 Mutation & Del/Dup Analysis NeoLAB T790M - NeoLAB FLT3 Mutation Analysis - NeoLAB IDH1 Mutation Analysis - NeoLAB IDH2 Mutation Analysis - NeoLAB inv(16), CBFB-MYH11 Translocation - NeoLAB (c-) Mutation Analysis - Liquid Biopsy NeoLAB Mutation Analysis - NeoLAB NPM1 Mutation Analysis - NeoLAB Mutation Analysis - NeoLAB PML-RARA Translocation, t(15;17) - NeoLAB RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) - NOTCH1 NPM1 Exon 4 PML-RARA Translocation, t(15;17) PMS2 Mutation & Del/Dup Analysis PTPN11 PLC-Gamma-2 PMS2 Mutation & Del/Dup Analysis RHOA RUNX1 RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) SETBP1 SF3B1 SRSF2 STAT3 T-Cell Gamma Gene Rearrangement T-Cell Beta Gene Rearrangement TERT Promoter TET2 TP53 TPMT Genotyping U2AF1 UGT1A1 Genotyping VHL WT1 ZRSR2 6 NeoGenomics Laboratories

7 Panels and Profiles AML Reflex Panel BRCA1/2 Mutation & Del/Dup Analysis BTK Inhibitor Acquired Resistance Panel BTK Inhibitor Primary Susceptibility Panel Hereditary Cancer Comprehensive Panel Hereditary Cancer Susceptibility for Pediatrics Hereditary DNA Repair Panel for Prostate Cancer Inherited Bone Marrow Failure Panel Lynch Syndrome MPN Extended Reflex Panel MPN Standard Reflex Panel NeoARRAY SNP/Cytogenetic Profile NeoLAB AML Profile - NeoLAB BTK Inhibitor Acquired Resistance Panel - NeoLAB MDS/CMML Profile - NeoLAB Myeloid Disorders Profile - NeoLAB Prostate - Liquid to Biopsy NeoLAB Solid Tumor Monitor - NeoTYPE AITL/Peripheral T-Cell Lymphoma Profile NeoTYPE AML Favorable-Risk Profile NeoTYPE AML Prognostic Profile NeoTYPE Brain Tumor Profile NeoTYPE Breast Tumor Profile NeoTYPE Cervical Tumor Profile NeoTYPE CLL Prognostic Profile NeoTYPE Colorectal Tumor Profile NeoTYPE Discovery Profile for Solid Tumors NeoTYPE Endometrial Tumor Profile NeoTYPE Esophageal Tumor Profile NeoTYPE Gastric Tumor Profile NeoTYPE GI Predictive Profile NeoTYPE GIST Profile NeoTYPE Head & Neck Tumor Profile NeoTYPE JMML Profile NeoTYPE Liposarcoma Fusion Profile NeoTYPE Liver/Biliary Tumor Profile NeoTYPE Lung Tumor Profile NeoTYPE Lymphoma Profile NeoTYPE MDS/CMML Profile NeoTYPE Melanoma Profile NeoTYPE MPN Profile NeoTYPE Myeloid Disorders Profile NeoTYPE Other Solid Tumor Profile NeoTYPE Ovarian Tumor Profile NeoTYPE Pancreas Tumor Profile NeoTYPE Precision Profile for Solid Tumors NeoTYPE Soft Tissue Tumor Profile NeoTYPE Thyroid Profile NGS ALK, NTRK, RET, ROS1 Fusion Profile NGS ALK, RET, ROS1 Fusion Profile NGS Comprehensive Sarcoma Fusion Profile NGS Ewing Sarcoma Fusion Profile NGS Non-Ewing Sarcoma Fusion Profile NGS Pediatric Sarcoma Fusion Profile NGS Rhabdomyosarcoma Fusion Profile NGS Thyroid Fusion Profile RAS/RAF Panel Tumor Mutation Burden Universal Fusion/Expression Profile Specimen and Ordering Information Specimen Requirements NeoGenomics molecular testing is routinely performed on blood, bone marrow aspirate, fixed cytogenetic pellets, fresh tissue, and formalin-fixed paraffin-embedded tissue of all types. Acceptable specimen types vary by test, so please see our website for requirements for the test of interest. Please inquire if you have an alternative specimen type as we can often accommodate these. Ordering Tests in panels or profiles may be ordered separately or in custom combinations. The most commonlyordered tests are shown, but for many diseases, more testing that encompasses emerging research and clinical trial opportunities is available. For an extended list of tests correlated with each tumor, please search by disease state on the NeoGenomics website. NeoGenomics Laboratories 7

8 NeoGenomics Laboratories is a specialized oncology reference laboratory providing the latest technologies, testing partnership opportunities, and interactive education to the oncology and pathology communities. We offer the complete spectrum of diagnostic services in molecular testing, FISH, cytogenetics, flow cytometry, and immunohistochemistry through our nation-wide network of CAP-accredited, CLIA-certified laboratories. Committed to research as the means to improve patient care, we provide Pharma Services for pharmaceutical companies, in vitro diagnostic manufacturers, and academic scientist-clinicians. We promote joint publications with our client physicians. NeoGenomics welcomes your inquiries for collaborations. Please contact us for more information Commonwealth Dr., Suite 9 Fort Myers, FL Phone: / Fax: neogenomics.com 2018 NeoGenomics Laboratories, Inc. All Rights Reserved. All other trademarks are the property of their respective owners. Rev